| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 6, 2025 | The Agency Expands to Santa Fe & Laurance Rassin Exhibits at Miami Art Week | Real estate firm The Agency opens its 150th office in Santa Fe. Contemporary artist Laurance Rassin showcases his work at Miami Art Week.
**The Agency Reaches Milestone in Santa Fe**
The Agency continues expansion. It opened its 150th offic... |
| Dec 3, 2025 | Contemporary Artist Laurance Rassin Exhibits During Miami Art Week | Contemporary artist Laurance Rassin announced today that he will be exhibiting at Miami Art Week, presented by PNC Bank.
MIAMI, Dec. 3, 2025 /PRNewswire-PRWeb/ -- Contemporary artist Laurance Rassin announced today that he will be exhibitin... |
| Nov 3, 2025 | Trump takes aim at laws in Colorado and other states that shield credit scores from medical debt | By Noam N. Levey, KFF Health News
The Trump administration took another step Tuesday to weaken protections for Americans with medical debt, issuing new guidance that threatens ongoing state efforts to keep that debt off consumers’ credit re... |
| Oct 22, 2025 | EQT Life Sciences’ ImCheck Therapeutics to be acquired by Ipsen in a transaction valued at up to EUR 1 billion | EQT Life Sciences’ ImCheck Therapeutics to be acquired by Ipsen in a transaction valued at up to EUR 1 billion
Wed, Oct 22, 2025 09:20 CET Report this content
Ipsen and ImCheck Therapeutics have entered into a definitive share purchase agre... |
| Jun 23, 2025 | Enterome: $19 Million Secured To Fund Development Of OncoMimics Immunotherapy To Treat Follicular Lymphoma | Enterome, a clinical-stage company developing first-in-class OncoMimics immunotherapies to treat cancer, announced that it has raised $19 million in new private financing to advance its lead clinical program, EO2463 OncoMimics immunotherapy... |
| Jun 12, 2025 | Enterome Raises $19M in Funding | Enterome, a Paris, France-based clinical-stage company developing OncoMimics immunotherapies to treat cancer, raised $19M in funding.
The round consisted of:
$9M from new investor The Institute for Follicular Lymphoma Innovation (IFLI)
$10M... |
| Apr 10, 2025 | Solu Therapeutics: A New Dawn in Cancer Treatment with $41 Million Series A Funding | Solu Therapeutics is on the rise. The Boston-based biotechnology company has just secured $41 million in Series A funding. This financial boost comes from a mix of new and existing investors, including heavyweights like Eli Lilly and The Le... |
| Apr 9, 2025 | Solu Therapeutics: $41 Million (Series A) Raised For Developing Therapies To Eliminate Disease-Driving Cells | Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, announced the completion of a $41 million Series A financing that included participation ... |
| Mar 25, 2025 | The Leukemia & Lymphoma Society BAML and Narrativa grow partnership to accelerate AI-automated regulatory documentation | The Leukemia & Lymphoma Society® (LLS) is the global leader in the fight against blood cancer.
Narrativa accelerates the potential of the workforce with Artificial Intelligence.
The Leukemia & Lymphoma Society Beat AML® Master Clini... |
| Mar 4, 2025 | National Politics | Republicans once wanted government out of health care. Trump voters see it differently | “We’re wandering around the country with a set of old, outdated frameworks about what ordinary Democrats and ordinary Republicans like,” he said.
Republican voters strongly back federal limits on the prices charged by drug companies and hos... |
| Dec 24, 2024 | Health | New childhood leukemia protocol is ‘tremendous win’ | Some children in the study were not getting blinatumomab so that researchers could gauge whether it worked better than the standard chemotherapy approach, which seeks to kill all of the body’s fast-growing cells — including, but not only, c... |
| Dec 13, 2024 | The Heart of the Matter: Plant Proteins and Their Role in Cardiovascular Health | In a world where food choices shape our health and the environment, a recent Harvard study sheds light on the power of plant proteins. It’s a call to action, urging us to rethink our plates. The findings are clear: more plants, less meat. T... |
| Dec 12, 2024 | Navigating the ups and downs of the lymphoma journey | Listen to this article
Navigating the ups and downs of the lymphoma journey
7 min
New: You can now listen to articles.
This audio is generated by an AI tool.
A lymphoma diagnosis often leaves patients with deep uncertainty. In Singapore, th... |
| Sep 3, 2024 | SKIES ACROSS NORTH AMERICA TO LIGHT UP THIS FALL IN SUPPORT OF BLOOD CANCER PATIENTS | The Leukemia & Lymphoma Society kicks off philanthropic campaign Light The Night; communities nationwide encouraged to learn why awareness and support is critical
RYE BROOK, N.Y., Sept. 3, 2024 /PRNewswire/ -- The Leukemia & Lymphom... |
| Aug 1, 2024 | Syndax Reports Second Quarter 2024 Financial Results and Provides Clinical and Business Update | – Axatilimab BLA in refractory chronic GVHD is under Priority Review; PDUFA action date of August 28, 2024 –
– Revumenib NDA in R/R KMT2Ar acute leukemia is being reviewed under RTOR; PDUFA action date of December 26, 2024 –
– Pivotal AUGME... |
| Jul 18, 2024 | Leukemia Survivor Named National 'Visionary of the Year' Redefining What's Possible After Diagnosis | The Leukemia & Lymphoma Society (LLS) Announces National Winners of Evolutionary 'Visionaries of the Year' Campaign; Funds Raised Will Help LLS Improve the Lives of Blood Cancer Patients and Their Families
RYE BROOK, N.Y., July 18, 2024... |
| Jul 10, 2024 | The Leukemia & Lymphoma Society (LLS) Invests Nearly $6.5 Million in Research Investigating the Causes of Inequitable Access to Blood Cancer Treatment and Care | LLS's Equity in Access Research Program Awards Four New Grants to Researchers Studying the Relationship Between Health Insurance and Access to Care and Interventions to Increase Therapeutic Clinical Trial Enrollment and Diversity
RYE BROOK,... |
| Jul 1, 2024 | The Leukemia & Lymphoma Society Welcomes Five Members to its Board of Directors | New Members Include Hematologists, NFL Vet, Operations & Communications Executives; All-Woman Executive Committee Named
RYE BROOK, N.Y., July 1, 2024 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) named five new members to it... |
| Jun 27, 2024 | 14-Year-Old High School Students from Los Angeles Earn The Leukemia & Lymphoma Society's (LLS) 2024 National Student Visionaries of the Year Title | Nashville-based High Schoolers Named Runners-Up in LLS's Philanthropic Campaign & First-Ever Team Member of the Year Title Awarded to Houston High School Student; Funds Raised Will Help Improve the Lives of Blood Cancer Patients & T... |
| May 8, 2024 | Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update | – NDA filing for revumenib in R/R KMT2Ar acute leukemia granted Priority Review under RTOR; PDUFA action date set for September 26, 2024 –
– BLA filing for axatilimab in chronic GVHD granted Priority Review; PDUFA action date set for August... |
| Feb 2, 2024 | Akel Homes Demonstrates Enthusiastic Support as Silver Benefactor for the 2024 LLS Black Tie Gala, Eager to Contribute to Life-Saving Cancer Research | The Akel Homes ladies pose for a picture at the 2024 LLS Dare to Disco Black Tie Gala.
Akel Homes proudly announces its support to the Leukemia & Lymphoma Society (LLS) as a Silver Benefactor sponsor of this year's Dare to Disco Black T... |
| Feb 2, 2024 | Senate could be site-neutral graveyard | Site-neutral payment policies are facing tough odds in the Senate amid intense lobbying from hospitals, after the House overwhelmingly backed the changes in a strong bipartisan vote.
Why it matters: The idea of having Medicare pay the same ... |
| Dec 9, 2023 | STAT readers on diagnostic tests, marijuana regulation, and pediatric oncology | STAT now publishes selected Letters to the Editor received in response to First Opinion essays to encourage robust, good-faith discussion about difficult issues. Submit a Letter to the Editor here, or find the submission form at the end of ... |
| Jul 9, 2023 | Biden Administration Takes Action Against Junk Insurance, Surprise Bills | The Biden-Harris administration announced Friday that it is taking a series of steps to lower healthcare costs for consumers, including cracking down on “junk” insurance.
Junk insurance refers to short-term health plans that are often lacki... |
| Apr 27, 2023 | Visionaries of the Year: A Campaign Powered by People Imagining a World Without Blood Cancer and Taking Action | The Leukemia & Lymphoma Society's philanthropic competition dedicates 10 weeks to end blood cancer
RYE BROOK, N.Y., April 27, 2023 /PRNewswire/ -- The global leader in the fight against blood cancers, The Leukemia & Lymphoma Society... |
| Apr 10, 2023 | Aggressive Lymphomas the Focus of New York Oncology Hematology’s 10th Annual Spring to Life Conference | SARATOGA SPRINGS, N.Y. (PRWEB) April 10, 2023
CME Credits Available for Medical Professionals Complimentary, In-Person Event May 5th & 6th in Saratoga Springs, NY
Aggressive lymphomas are the focus of New York Oncology Hematology’s 10th... |
| Mar 16, 2023 | The Cancer Moonshot will never take off without economists and finance experts | In February, President Biden announced the reboot of the Cancer Moonshot and vowed to reduce cancer mortality by 50 percent in the next 25 years. It’s a goal that’s both lofty and achievable — but only if the advances in science are accompa... |
| Feb 7, 2023 | Narrativa Brings Artificial Intelligence-Generated Reporting to the Clinical Trial Process in the Life Sciences Industry | Narrativa Joins The Leukemia & Lymphoma Society in Groundbreaking Precision Medicine Approach to Treat Acute Myeloid Leukemia
The Leukemia & Lymphoma Society® (LLS) is the global leader in the fight against blood cancer.
Narrativa l... |
| Jan 23, 2023 | Unusual blood cancer cases among US troops who manned nuclear missile silos at a base in Montana are raising new questions for the military | In this June 24, 2014 file photo, a gate is closed at an ICBM launch control facility in the countryside outside Minot, N.D., on the Minot Air Force Base. AP Photo/Charlie Riedel, File
US military officers who worked at a nuclear missile ba... |
| Jan 17, 2023 | BioInvent Selected to The Leukemia & Lymphoma Society’s Therapy Acceleration Program and Receives $3 million Strategic Equity Investment | Strategic equity investment of USD 3 million to support clinical advancement of BI-1206 in Non-Hodgkin's Lymphoma
Supports also clinical development of BI-1808 in cutaneous T-cell lymphoma
LLS TAP is a strategic funding initiative to accele... |
| Nov 2, 2022 | Зачем обычному человеку криптовалюта? | Криптовалюта еще не стала платежным инструментом в большинстве стран, а сам термин для многих по-прежнему звучит пугающе. Однако биткоином, эфиром и другими криптовалютами с каждым годом можно оплачивать всё больше сервисов. Особенно – когд... |
| Oct 16, 2022 | Cancer drug biotech Enliven shifts to reverse to move forward as a public company | Drugs from a class called tyrosine kinase inhibitors have become standard treatments for some cancers, but the improved survival of patients taking these medicines introduces a new problem. As patients live longer, many decide they no longe... |
| Sep 21, 2022 | Seniors’ drug costs are about to be slashed — here’s what you need to know | (BPT) - Today, Medicare beneficiaries across the country face a devastating predicament: Often, they can manage serious conditions like cancer by taking daily prescription drugs — but there’s no limit to what they might owe for the drugs th... |
| Jul 8, 2022 | 11 Actions To Help Nonprofit Professionals Continue Finding Joy In Their Work | Nonprofits do important work within communities, but when organizations take a more hands-on-the-ground approach, leaders, staff members and volunteers alike may all find themselves mentally and physically exhausted in the long term. |
| Jun 6, 2022 | Alex Akel from Akel Homes announced Leukemia & Lymphoma Society’s Man of the Year Runner Up, raising over $110K throughout the 10-week campaign | Leukemia & Lymphoma Society’s MWOY Finalists
LAKE WORTH, Fla. (PRWEB) June 06, 2022
The 2022 Leukemia & Lymphoma Society's (LLS) Palm Beach Treasure Coast Man and Woman of the Year (MWOY) Campaign has concluded, raising over $1.0 mi... |
| Mar 25, 2022 | Novartis receives positive CHMP opinion for Jakavi® to treat acute and chronic graft-versus-host disease | CHMP opinion based on Phase III REACH2 and REACH3 trials that showed Jakavi improved response rates and failure-free survival compared to best available therapy1,2
Graft-versus-host disease (GvHD) is a serious and debilitating complication ... |
| Mar 15, 2022 | ER Injury Attorneys Is Bronze Sponsor of The Leukemia & Lymphoma Society’s 2022 Students of the Year Campaign | Bronze Sponsor of 2022 Students of the Year Campaign LLS’s 2022 Students of the Year campaign recognizes the philanthropic efforts of high-school student leaders who help raise funds in honor of children who have fought and survived blood c... |
| Jan 19, 2022 | Burlington Stores : LLS End of Campaign Media Release | FOR IMMEDIATE RELEASE
Media Contacts:
Kristin Hoose
The Leukemia & Lymphoma Society [email protected]
Kaitlyn Adams
Tierney
[email protected]
Burlington Stores' 20th Consecutive In-Store Fundrai... |
| Oct 18, 2021 | Colin Powell’s Passing Highlights The Need For More People To Get Vaccinated Against Covid-19 | Ex-secretary of State Colin Powell has passed away due to complications from Covid-19, according to ... [+] his family. Powell also had multiple myeloma, a type of blood cancer. (Photo by Brooks Kraft/CORBIS/Corbis via Getty Images) Corbis ... |
| Oct 18, 2021 | Burlington Stores and The Leukemia & Lymphoma Society Celebrate 20 Years of Partnership in the Fight Against Blood Cancer | RYE BROOK, N.Y., Oct. 18, 2021 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS), the global leader in the fight against blood cancer, and Burlington Stores, the national retailer delivering amazing deals to customers every time the... |
| Oct 18, 2021 | Burlington Stores : and The Leukemia & Lymphoma Society Celebrate 20 Years of Partnership in the Fight Against Blood Cancer | RYE BROOK, N.Y., Oct. 18, 2021 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS), the global leader in the fight against blood cancer, and Burlington Stores, the national retailer delivering amazing deals to customers every time the... |
| Oct 14, 2021 | BeiGene : Announces First Regulatory Approval in Australia for BRUKINSA® (Zanubrutinib) for Treatment of Patients with Waldenström's Macroglobulinemia - Form 8-K | BeiGene Announces First Regulatory Approval in Australia for BRUKINSA® (Zanubrutinib) for Treatment of Patients with Waldenström's Macroglobulinemia
Represents BRUKINSA's Second Recent Approval in the Asia-Pacific Region, Following October ... |
| Sep 21, 2021 | Women in Pharma: Navigating the Career Jungle Gym, Upcoming Online Panel Discussion Hosted by Xtalks | Our panel of experts will discuss the increase in female representation in STEM fields, the importance of mentoring and coaching and how the biotech and pharmaceutical industries can support and advance more female leaders.
TORONTO (PRWEB) ... |
| Sep 13, 2021 | New Study Shows Most Blood Cancer Patients Benefit from an Additional COVID-19 Vaccine Dose | |
| Jul 26, 2021 | $2.1 million campaign pushes UFCW Canada lifetime fundraising for The Leukemia & Lymphoma Society of Canada past $47.2 million | TORONTO, July 26, 2021 (GLOBE NEWSWIRE) -- Despite an extraordinarily challenging year, UFCW Canada members and Local Unions were undeterred in their extraordinary ongoing fundraising efforts, raising more than $2.1 million dollars in their... |
| Jul 22, 2021 | Study from The Leukemia & Lymphoma Society Shows COVID-19 Vaccine Is Safe But 25% Of Blood Cancer Patients Do Not Produce Detectable Antibodies | |
| Jun 30, 2021 | Relentless High School Students Forge Ahead for a Future Without Cancer | |
| May 13, 2021 | The Leukemia & Lymphoma Society Launches Impact Research Grants To Help Underserved Patients Access Clinical Trials | |
| Apr 22, 2021 | The Leukemia & Lymphoma Society Therapy Acceleration Program® (LLS TAP) Announces Five New Investments Supporting Next Generation Cell Therapies and a Novel Immune Checkpoint Inhibitor | |
| Apr 21, 2021 | Thousands Nationwide Reimagine Iconic Stair Climb to Take Down Cancer | |
| Apr 19, 2021 | Integrated Medical Communications Launches New Quarterly Print Publication | I’m proud that The Leukemia & Lymphoma Society (LLS) asked me to be the editor-in-chief of the LLS section of Multiple Myeloma Today,” said Saad Usmani, M.D. “More than ever, we need this type of publication to share updates on the rese... |
| Apr 15, 2021 | Everyday Heroes Fight for a Cancer-Free Future | RYE BROOK, N.Y., April 15, 2021 /PRNewswire/ -- Every three minutes, one person in the U.S. is diagnosed with a blood cancer. But, The Leukemia & Lymphoma Society (LLS), the global leader in the fight against blood cancer, is making gam... |
| Apr 15, 2021 | Everyday Heroes Fight for a Cancer-Free Future | |
| Mar 10, 2021 | Leading Direct Lender and Mortgage Broker Celebrates Women in Mortgage During Women’s History Month | SANTA ANA, Calif. (PRWEB) March 10, 2021
Women have paved the way in finance since the late 1800’s with Louise M. Weiser serving as bank president in Vermont, 1875. The women at Arbor Financial Group are continuing the tradition. Over 44% w... |
| Feb 18, 2021 | The Leukemia & Lymphoma Society Launches National Patient Registry to Answer Crucial COVID-19 Questions for Blood Cancer Patients | |
| Feb 10, 2021 | Burlington Stores & its Customers Raise Nearly $4 Million for The Leukemia & Lymphoma Society (LLS) in the Fight Against Blood Cancer | RYE BROOK, N.Y., Feb. 10, 2021 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS), the global leader in the fight against blood cancer, and Burlington Stores, the national retailer delivering amazing deals to customers every time the... |
| Dec 1, 2020 | Pond Lehocky Gives Back to 25 Charities Across the Nation This Holiday Season During Its 4th Annual ‘25 Days of Giving’ | The holidays may look different this year, but the needs are greater than ever. Pond Lehocky is proud to remain committed to community and providing positive moments during tough times.
PHILADELPHIA (PRWEB) December 01, 2020
The holidays ma... |
| Sep 24, 2020 | The Leukemia & Lymphoma Society and Burlington Stores Celebrate 19 Years of Partnership in the Fight Against Blood Cancer | RYE BROOK, N.Y., Sept. 24, 2020 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS), the world's largest nonprofit dedicated to fighting blood cancer, and the national off-price retailer, Burlington Stores, team up for the 19th consec... |
| Sep 24, 2020 | The Leukemia & Lymphoma Society and Burlington Stores Celebrate 19 Years of Partnership in the Fight Against Blood Cancer | |
| Sep 9, 2020 | The Leukemia & Lymphoma Society Launches First Clinical Trial Specifically for Blood Cancer Patients with COVID-19 | |
| Sep 1, 2020 | Blood Cancer Patients Need Support Now More Than Ever | |
| Aug 13, 2020 | Communities Nationwide Remain Laser-Focused on Helping Cancer Patients Who Can't Wait For Pandemic to Go Away | |
| Jun 16, 2020 | By phone, cancer patients reveal their Covid-19 angst — and seek help | Clinical trials have always represented hope for people with cancer. Whether someone is newly diagnosed or has exhausted most treatment options, trials can provide a crucial, alternate treatment. Covid-19 has upended that lifeline, along wi... |
| Nov 20, 2019 | Letting academic medical centers make CAR-T drugs would save billions | Draw blood from someone with cancer. Engineer their blood cells to seek and destroy cancer. Reinfuse the cells and watch the cancer melt away. Chimeric antigen receptor T cell therapy (CAR-T) sounds like science fiction. But it’s the next f... |
| Jul 12, 2018 | Nohla Therapeutics raises another $11M to support leukemia treatment trials | Nohla Therapeutics founder and Chief Science Officer Colleen Delaney (left) and CEO Kathleen Fanning. (GeekWire Photo / Clare McGrane)
Seattle startup Nohla Therapeutics has reeled in another $11 million to further develop its leukemia trea... |
| Jun 11, 2015 | PureWrist Puts Contactless Payments Inside A Bracelet | Launched on Indiegogo last week, PureWrist is a fashionable silicone bracelet that contains an embedded NFC payment chip that lets you go through life without Apple Pay.
The chip inside the bracelet is powered by the same technology found i... |
| May 14, 2014 | Bid To Meet With SV Angel, First Round Capital And Others In VC Auction For Cancer Charity | Getting a meeting with a top venture capitalist is tough unless you’ve got the right connections. For all the talk of meritocracy around product development, raising money is still a bit of an old boy’s club. The Leukemia & Lymphoma Soc... |
| May 29, 2013 | Meet Rhett, The Reason You Should Donate Money To Charity To Hang Out With A VC [TCTV] | How much is a dinner with SV Angel co-founder and managing partner David Lee worth? When you put it into the context of where the money will be going, the answer should be “it’s almost priceless.” Today, I got to sit down with Lee and a spe... |
| May 1, 2013 | Celator offers disruptive approach to chemo treatment options for acute myeloid leukemia | The Princeton, New Jersey-based treatment developer’s phase 3 clinical study will be a 300 patient, randomized, controlled study comparing CPX-351 to conventional cytarabine and daunorubicin therapy with a primary endpoint of overall surviv... |
| Apr 16, 2012 | Win A Meeting With Sean Parker, SV Angel & More In An Auction To Benefit Cancer Research | Unfortunately, an estimated 148,040 people will be diagnosed with leukemia, lymphoma or myeloma in 2012. Whether it be blood-based, or any other form, cancer has and will touch many of us. Since its founding in 1949, The Leukemia & Lymp... |
| Dec 30, 2011 | Celator Pharmaceuticals raising $5 million for cancer treatments | The Celator’s approach to cancer treatment is based on a synergistic ratio of drugs to improve tumor cell kill and locks the synergistic ratio in a drug-delivery vehicle to maintain the ratio in patients, according to its website. The goal ... |
| Mar 13, 2007 | Help Me Hit $2000+ By the 15th | I promised I wouldn’t bother you all very much, but I’m coming up to a deadline in my fund-raising and thought I’d depend on the kindness of strangers. I’m running a marathon in June to help the Leukemia & Lymphoma Society and need to r... |
| Feb 20, 2007 | A Quick Call for Help | I’m running a marathon in June. I’m taking part in Team in Training, a part of the the Leukemia & Lymphoma Society, and they offer training and support during the ordeal/sporting event to volunteers who agree to raise money for them. Th... |
| Celator Pharmaceuticals raising $5 million for cancer treatments | Celator Pharmaceuticals, a drug development company, is raising $5 million as its drug therapy for acute myeloid leukemia moves through phase 2 clinical trials.
In its latest financing round, the company, which has offices in Princeton, New... |
| New immune-based approaches stir hope in non-Hodgkin’s lymphoma | Non-Hodgkin’s lymphoma (NHL), one of the most common hematologic cancers in the U.S.,1 is a heterogeneous group of diseases with more than 60 identified subtypes.2 Each subtype is characterized by distinct clinical presentation, morphology,... |
| FDA decision for BMS drug Orencia marks a first for acute graft versus host disease | Patients undergoing a bone marrow or stem cell transplant face the prospect of a dangerous and potentially fatal immune response. The FDA has approved Bristol Myers Squibb drug Orencia as a way to stave off this condition, called acute graf... |
| Biomarker test may drive treatment considerations for most common adult leukemia | Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults.1,2 Each year, approximately 20,000 Americans are diagnosed with CLL, with new cases at a rate of 4.9 per 100,000 in adult men and women.3 The estimated five-year surv... |
| When is it safe to discontinue TKI therapy in people with chronic myeloid leukemia? | About 1 in every 526 people in the U.S. will be diagnosed with chronic myeloid leukemia (CML) this year, but most of these people will achieve their normal life expectancy thanks to tyrosine kinase inhibitors (TKIs).
When it was approved in... |
| Examining CLL: Personal connection driving treatment research | Chronic lymphocytic leukemia (CLL) accounts for 38% of all leukemia diagnoses.1 Due to CLL’s prominence, the treatment landscape is continuing to evolve with combination therapies and various chemotherapy-free treatment options.
To better u... |
| Q&A: AstraZeneca on the evolving landscape and future of hematology | Leveraging its strength in oncology, AstraZeneca has established hematology as one of four oncology disease areas of focus. In recent years, AstraZeneca has advanced an exciting portfolio of FDA-approved and investigational therapies in var... |
| How Pfizer scientists are doubling down to conquer blood disorders | Millions of people around the world suffer from blood disorders today. That’s why this December, blood disease specialists from around the globe are convening in New Orleans to share the latest advancements in the field during the 64th Annu... |
| Celator offers disruptive approach to chemo treatment options for acute myeloid leukemia | A drug developer has done a final closing for its latest financing round to advance its new twist on chemotherapy treatment for 60- to 75-year-old patients with secondary acute myeloid leukemia through phase 3 clinical trials. Celator Pharm... |
| Leveraging 40 years of strength in oncology with a vision to redefine care for blood cancer patients | Nearly every three minutes, one person in the United States (US) is diagnosed with a blood cancer.1 The medical and scientific communities have made great strides in the understanding and treatment of blood cancers in recent years; however,... |
| A look at the promise of IL-15-based immunotherapies in the treatment of cancer | By Jonathan Zalevsky, PhD, Chief Research & Development Officer, Nektar Therapeutics
For decades, researchers have worked to harness the potential of the body’s immune system to fight cancer. One novel approach being explored is the use... |
